TTOO News and Press, T2 Biosystems Inc. From 01/11/22

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical trial evaluating the performance of its T2Biothreat® Panel designed to support a submissi...

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initiation of a U.S. multi-site clinical trial evaluating the performance of its T2Resistance ® Panel designed to ...

T2 Biosystems (NASDAQ:TTOO) perks up 3.3% premarket after announcing that its T2SARS-CoV-2 Panel detects the Omicron COVID-19 variant (B.1.1.529). To confirm that the T2SARS-CoV-2 Panel would detect the new variant, in silico analysis was performed using sequences in the GISAID data...

LEXINGTON, Mass., Dec. 01, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO),  a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel detects the Omicron COVID-19 variant (B.1.1.529). The World Health Organizat...

LEXINGTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of a territory exclusive distribution agreement in Taiwan. Under the terms of the agreement, T2 Biosys...

LEXINGTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Foru...

LEXINGTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced it will participate in the 7 th annual World Anti-Microbial Resistance Congress (WAMR) taking place on November 8 and 9 in Washin...

T2 Biosystems, Inc. (TTOO) Q3 2021 Results Earnings Conference Call November 04, 2021, 04:30 PM ET Company Participants Philip Taylor - Investor Relations. John Sperzel - Chairman & CEO John Sprague - CFO Conference Call Participants Presentation Operator Good afternoon, and welcome to th...

T2 Biosystems (NASDAQ:TTOO): Q3 GAAP EPS of -$0.08 beats by $0.01. Revenue of $7.43M (+41.5% Y/Y) beats by $1.63M. Shares +4%. Press Release The Company is raising its revenue expectations to reflect its third quarter results and now expects revenue for the full year 2021 to be between $25.0 ...

T2 Biosystems (NASDAQ:TTOO) announces the appointment of Brett Giffin as its Chief Commercial Officer, effective November 8, 2021. Giffin brings a wealth of industry experience and commercial leadership to T2 Biosystems, having served as Chief Executive Officer for two early st...